Baxter stock faces FDA warning letter over Illinois facility issues

Markets Investing.com By Investing.com 20 Oct 2026 19:50 1 min read
Baxter stock faces FDA warning letter over Illinois facility issues

Covered in this story

Analyst targets on Baxter International

Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.

Call it yourself

No member calls on $BAX yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.

Make the first call on Baxter International →
Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.